Rhumbline Advisers Grifols Sa Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Grifols Sa stock. As of the latest transaction made, Rhumbline Advisers holds 11,303 shares of GRFS stock, worth $108,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,303
Previous 12,176
7.17%
Holding current value
$108,847
Previous $86,000
18.6%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GRFS
# of Institutions
170Shares Held
153MCall Options Held
42.9KPut Options Held
82.4K-
Brandes Investment Partners, LP La Jolla, CA28MShares$270 Million2.4% of portfolio
-
Capital World Investors Los Angeles, CA21.7MShares$209 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.6MShares$179 Million32.54% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.6MShares$121 Million5.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.67MShares$93.1 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.54B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...